v3.25.4
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Summary of Segment Reporting
The table below summarizes the significant expense categories regularly reviewed by the CODM for the years ended December 31, 2025, and 2024:
 
           
 
Year Ended
 December 31,
 
(in thousands)
  2025     2024  
Revenue
 $8,270   $8,740 
Gross Profit
  5,124    5,676 
Gross profit %
  62.0%   64.9%
Operating expenses:
         
General and administrative
  5,803    5,637 
Sales and Marketing
  6,703    6,254 
Development
  1,296    1,645 
Clinical, Quality, Regulatory
  2,301    2,650 
Total Expenses
  16,103    16,186 
Stock-Based Compensation
  127    478 
Other Expense
  6,415    177 
Net loss
  (17,521   (11,165